G

M

GONZÁLEZ-RIVERA , Milagros

Last name: GONZÁLEZ-RIVERA

First name: Milagros

February 12, 2024 (v1)

Publication

Metadata-only

Prospective study of the impact of the Prosigna assay on adjuvant clinical decision-making in unselected patients with estrogen receptor-positive, HER2-negative, node-negative early-stage breast cancer

Martín, Miguel González-Rivera, Milagros Morales, Serafín

Purpose: Improved understanding of risk of recurrence (ROR) is needed to reduce cases of recurrence and more effectively treat breast cancer patients. The purpose of this study was to examine how a gene-expression profile (GEP), identified by Prosigna, influences physician adjuvant treatment selection for early breast cancer (EBC) and the...

Uploaded on: February 14, 2024